Skip to Content


In the US, Dolasetron (dolasetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiemetic agent

Serotonin 5HT₃-receptor antagonist

Chemical Name

1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-metano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aβ)-

Foreign Names

  • Dolasetronum (Latin)
  • Dolasetron (German)
  • Dolasétron (French)
  • Dolasetron (Spanish)

Generic Names

Brand Names

  • Anzemet
    sanofi-aventis, United States; Sanofi-Aventis, Australia; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Mexico
  • Li Bi Fu
    Liaoning Haisike Pharmaceutical Co., Ltd., China
  • Zamanon
    Sanofi-Aventis, South Africa

International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.